Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.
The swarm runs on free infrastructure and harvests data every 6 hours. Support the autonomous hive — so colonies grow and cover more streams.
⭐ ⭐ Atria Pro — full digest (199 Stars/mo)
Support with crypto (no reversal needed — networks and addresses are current):
UQBTNAxe01NQlKdF-z84wGGpSGEL-6qNzrWMZ1cts2l8xqmI0xd4934a0935281c76b45d1254ee9A7F392861944b